Timmis A, Townsend N, Gale CP, Torbica A, Lettino M, Petersen SE, et al. European society of cardiology: cardiovascular disease statistics 2019. Eur Heart J. 2020;41(1):12–85.
Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;394(10204):1145–58.
Article PubMed PubMed Central Google Scholar
Musunuru K, Kathiresan S. Genetics of common, complex coronary artery disease. Cell. 2019;177(1):132–45.
Article CAS PubMed Google Scholar
Sharpe N. Cardiac remodeling in coronary artery disease. Am J Cardiol. 2004;93(9):17–20.
Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodeheffer RJJJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289(2):194–202.
Gaasch WH, Zile MR. Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry. J Am Coll Cardiol. 2011;58(17):1733–40.
Lindholm D, Lindback J, Armstrong PW, Budaj A, Cannon CP, Granger CB, et al. Biomarker-based risk model to predict cardiovascular mortality in patients with stable coronary disease. J Am Coll Cardiol. 2017;70(7):813–26.
Li XS, Obeid S, Klingenberg R, Gencer B, Mach F, Räber L, et al. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. Eur Heart J. 2017;38(11):814–24.
CAS PubMed PubMed Central Google Scholar
Fatima T, Hashmi S, Iqbal A, Siddiqui AJ, Sami SA, Basir N, et al. Untargeted metabolomic analysis of coronary artery disease patients with diastolic dysfunction show disturbed oxidative pathway. Metabolomics. 2019;15(7):1–12.
Zhang L, Wei TT, Li Y, Li J, Fan Y, Huang FQ, et al. Functional metabolomics characterizes a key role for N-acetylneuraminic acid in coronary artery diseases. Circulation. 2018;137(13):1374–90.
Article CAS PubMed Google Scholar
Ussher JR, Elmariah S, Gerszten RE, Dyck JR. The emerging role of metabolomics in the diagnosis and prognosis of cardiovascular disease. J Am Coll Cardiol. 2016;68(25):2850–70.
Article CAS PubMed Google Scholar
Tremblay BL, Guénard F, Lamarche B, Pérusse L, Vohl MC. Familial resemblances in human plasma metabolites are attributable to both genetic and common environmental effects. Nutr Res (New York, NY). 2019;61:22–30.
Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016;17(7):451.
Article CAS PubMed PubMed Central Google Scholar
Deelen J, Kettunen J, Fischer K, van der Spek A, Trompet S, Kastenmuller G, et al. A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals. Nat Commun. 2019;10(1):3346.
Article PubMed PubMed Central Google Scholar
Yu B, Heiss G, Alexander D, Grams ME, Boerwinkle E. Associations between the serum metabolome and all-cause mortality among African Americans in the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol. 2016;183(7):650–6.
Article PubMed PubMed Central Google Scholar
Balasubramanian R, Paynter NP, Giulianini F, Manson JE, Zhao Y, Chen JC, et al. Metabolomic profiles associated with all-cause mortality in the Women’s Health Initiative. Int J Epidemiol. 2020;49(1):289–300.
Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575–84.
Article CAS PubMed PubMed Central Google Scholar
Wurtz P, Havulinna AS, Soininen P, Tynkkynen T, Prieto-Merino D, Tillin T, et al. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation. 2015;131(9):774–85.
Article PubMed PubMed Central Google Scholar
Vignoli A, Tenori L, Giusti B, Takis PG, Valente S, Carrabba N, et al. NMR-based metabolomics identifies patients at high risk of death within two years after acute myocardial infarction in the AMI-Florence II cohort. BMC Med. 2019;17(1):3.
Article PubMed PubMed Central Google Scholar
Hu JR, Coresh J, Inker LA, Levey AS, Zheng Z, Rebholz CM, et al. Serum metabolites are associated with all-cause mortality in chronic kidney disease. Kidney Int. 2018;94(2):381–9.
Article CAS PubMed PubMed Central Google Scholar
Yin J, Liao SX, He Y, Wang S, Xia GH, Liu FT, et al. Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack. J Am Heart Assoc. 2015;4(11):e002699.
Article PubMed PubMed Central Google Scholar
Mueller DM, Allenspach M, Othman A, Saely CH, Muendlein A, Vonbank A, et al. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control. Atherosclerosis. 2015;243(2):638–44.
Article CAS PubMed Google Scholar
Zhao W, Zhao J, Rong J. Pharmacological modulation of cardiac remodeling after myocardial infarction. Oxid Med Cell Longevity. 2020;2020:8815349.
Karagiannidis E, Sofidis G, Papazoglou AS, Deda O, Panteris E, Moysidis DV, et al. Correlation of the severity of coronary artery disease with patients’ metabolic profile- rationale, design and baseline patient characteristics of the CorLipid trial. BMC Cardiovasc Disord. 2021;21(1):79.
Article CAS PubMed PubMed Central Google Scholar
Poss AM, Maschek JA, Cox JE, Hauner BJ, Hopkins PN, Hunt SC, et al. Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease. J Clin Investig. 2020;130(3):1363–76.
Article CAS PubMed PubMed Central Google Scholar
Yu N, Wang R, Liu B, Zhang L. Bibliometric and visual analysis on metabolomics in coronary artery disease research. Front Cardiovasc Med. 2022;9:804463.
Article CAS PubMed PubMed Central Google Scholar
Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, et al. Identification of new biosignatures for clinical outcomes in stable coronary artery disease—the study protocol and initial observations of a prospective follow-up study in Taiwan. BMC Cardiovasc Disord. 2017;17(1):42.
Article PubMed PubMed Central Google Scholar
Yu E, Ruizcanela M, Guaschferré M, Zheng Y, Toledo E, Clish CB, et al. Increases in plasma tryptophan are inversely associated with incident cardiovascular disease in the Prevención con Dieta Mediterránea (PREDIMED) study. J Nutr. 2017;147(3):314–22.
CAS PubMed PubMed Central Google Scholar
Zuo H, Ueland PM, Ulvik A, Eussen SJPM, Vollset SE, Nygård O, et al. Plasma biomarkers of inflammation, the kynurenine pathway, and risks of all-cause, cancer, and cardiovascular disease mortality: The Hordaland Health Study. Am J Epidemiol. 2016;183(4):kwv42.
Verheyen N, Meinitzer A, Grubler MR, Ablasser K, Kolesnik E, Fahrleitner-Pammer A, et al. Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial. Clin Chem Lab Med. 2017;55(7):1034–42.
Article CAS PubMed Google Scholar
Sallée M, Dou L, Cerini C, Poitevin S, Brunet P, Burtey S. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease. Toxins. 2014;6(3):934–49.
Article PubMed PubMed Central Google Scholar
Wang B, Liu S, Li L, Yao Q, Song R, Shao X, et al. Non-thyroidal illness syndrome in patients with cardiovascular diseases: a systematic review and meta-analysis. Int J Cardiol. 2017;226:1–10.
Mindikoglu AL, Opekun AR, Putluri N, Devaraj S, Sheikh-Hamad D, Vierling JM, et al. Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis. Transl Res. 2018;195:25–47.
Article CAS PubMed Google Scholar
Xiao Y, Zhang Y, Wang M, Li X, Su D, Qiu J, et al. Plasma S-adenosylhomocysteine is associated with the risk of cardiovascular events in patients undergoing coronary angiography: a cohort study. Am J Clin Nutr. 2013;98(5):1162–9.
Article CAS PubMed Google Scholar
Zawada AM, Rogacev KS, Hummel B, Berg JT, Friedrich A, Roth HJ, et al. S-adenosylhomocysteine is associated with subclinical atherosclerosis and renal function in a cardiovascular low-risk population. Atherosclerosis. 2014;234(1):17–22.
Article CAS PubMed Google Scholar
Li XS, Obeid S, Klingenberg R, Gencer B, Mach F, Raber L, et al. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. Eur Heart J. 2017;38(11):814–24.
留言 (0)